NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Macro Biologics

Macro Biologics

Private
Carlsbad, CaliforniaHealthcare & Life Scienceshttps://www.macrobiologics.com/

Last Round

Grant

Dec 16, 2025

Total Funding Raised

$18.57M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Macro Biologics is a biotechnology company that develops synthetic biological polymers for breakthrough therapeutics, next-generation medical devices, and advanced biomaterials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices, Defense Tech

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

synthetic biologyantimicrobial polymersbiomaterialswound careantibiotic resistancebiocompatible polymersbiodegradable polymerstopical antimicrobialsurgical infectionamino-acid polymersbiotechprolonged field caredefense medicinedrug developmentmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Macro Biologics Comps

Public and private peers based on sector, stage, and business model.

Macro Biologics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Macro Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2025
Series ASep 4, 2024
Early FundingAug 14, 2023
GrantJun 6, 2023
GrantJun 22, 2020
Convertible Debt
Feb 12, 2020

Key People

Founding team and executive leadership

Daniel Gowen-Huang

Chief Operating Officer

Executive Team

Macro Biologics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 117% MoM.

  • Oct 24, 2017

    Secured $2.48M from CARB-X, Wellcome Trust, and PHEMCE.

Macro Biologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Macro Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Macro Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlsbad, California
Employee Range9
Year Founded2011
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.